The role of modulation of antioxidant enzyme systems in the treatment of neurodegenerative diseases.

Obuobi, Sybil; Karatayev, Sanzhar; Chai, Christina Li Lin; Ee, Pui Lai Rachel; Mátyus, Peter

Obuobi, Sybil; Karatayev, Sanzhar; Chai, Christina Li Lin; Ee, Pui Lai Rachel; Mátyus, Peter.

Obuobi S; a Department of Pharmacy , National University of Singapore , Singapore.
Karatayev S; a Department of Pharmacy , National University of Singapore , Singapore.
Chai CL; a Department of Pharmacy , National University of Singapore , Singapore.
Ee PL; a Department of Pharmacy , National University of Singapore , Singapore.
Mátyus P; b Department of Organic Chemistry , Semmelweis University , Budapest , Hungary , and.

J Enzyme Inhib Med Chem ; 31(sup3): 194-204, 2016.

Article en En | MEDLINE | ID: mdl-27389167

Asunto(s)

Antioxidantes/metabolismo; Factor 2 Relacionado con NF-E2/metabolismo; Enfermedades Neurodegenerativas/tratamiento farmacológico; Enfermedades Neurodegenerativas/enzimología; Fármacos Neuroprotectores/farmacología; Animales; Humanos; Enfermedades Neurodegenerativas/metabolismo; Fármacos Neuroprotectores/síntesis química; Fármacos Neuroprotectores/química; Estrés Oxidativo/efectos de los fármacos

Palabras clave

Keap 1; Nrf2; ROS; neurodegeneration; oxidative stress

Search on Google

Imprimir

XML

PubMed Links

Banco de datos: MEDLINE Asunto principal: Fármacos Neuroprotectores / Enfermedades Neurodegenerativas / Factor 2 Relacionado con NF-E2 / Antioxidantes Límite: Animals / Humans Idioma: En Año: 2016 Tipo del documento: Article

Search on Google

Imprimir

XML

PubMed Links